Navigation Links
Oncolytics Biotech(R) Inc. Announces Terms of Unit Offering
Date:11/18/2009

l/carboplatin trial for patients with platinum-failed head and neck cancers, its other clinical development and research and development activities, and for general corporate and working capital purposes.

The transaction is expected to close on or about November 25, 2009, subject to satisfaction of customary closing conditions, including the receipt of all necessary regulatory and stock exchange approvals.

The securities are being offered in each of the Canadian provinces of British Columbia, Alberta, Manitoba and Ontario by way of a prospectus supplement to Oncolytics' base shelf short form prospectus and in the United States pursuant to a prospectus supplement to Oncolytics' effective Form F-10 shelf registration statement (File # 333-151513) previously filed with the United States Securities and Exchange Commission on June 6, 2008, as amended on June 17, 2008, pursuant to the United States Securities Act of 1933, as amended. Copies of the prospectus supplement and accompanying base prospectus relating to the offering may be obtained from the Securities and Exchange Commission website at http://www.sec.gov, from the System for Electronic Document Analysis and Retrieval (SEDAR) website at http://www.sedar.com or from the underwriters at:

    Oppenheimer & Co. Inc.
    Attention: Syndicate Prospectus Department
    300 Madison Avenue, 5th Floor
    New York, NY, 10017
    Telephone number: (212) 667-8563
    Email: EquityProspectus@opco.com

    Canaccord Adams Inc.
    Attention: Ron Sedran
    Brookfield Place
    161 Bay Street, Suite 3000
    Toronto, Ontario, Canada
    M5J 2S1
    Telephone number (416) 869-3198
    Email: ron.
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Oncolytics Biotech Inc. announces approval for UK clinical trial
2. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
3. Albireo Announces Positive Clinical Data on A3309 in Patients with Chronic Idiopathic Constipation
4. AMA Optics Announces New Brightness Acuity Meter -- Documents Disabling Glare from Cataract
5. Tyco International Announces Exchange Rate for Quarterly Dividend
6. Shopko Announces Launch of e-Commerce Platform
7. Driven by Customer Feedback, BodyMedia, Inc. Announces Major Enhancements and Brand Change for GoWear Fit
8. Encorium Reports Third Quarter 2009 Financial Results; Announces Date of Annual Stockholder Meeting
9. United American Healthcare Corporation Announces Fiscal 2010 First Quarter Results
10. MedImmune Announces Winners of the 4th Respiratory, Immunology and Autoimmunity Research Abstract Competition
11. US Farms, Inc. Announces Completion of Construction for New 3000 Square Foot Greenhouse Shipping and Packing Facility for Nursery Division
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 17, 2014 ICS Learning Group, Inc. ... Excellence in Training for the Best Use of Games ... on an online operational safety training module that ICS ... operation. Using an approach that combined realistic 3D ... that was similar to a video game, including competition ...
(Date:9/17/2014)... 2014 Health.Verticalize, a healthcare marketing company ... health insurance options in the 2014 open enrollment period, ... Moving forward Health Network will be using ... has intentionally remained out of the spotlight for the ... single website to its present position with dozens of ...
(Date:9/16/2014)... Recently, BamboofloorChina.com, the popular online supplier ... of strand woven bamboo floors to its ... big promotion for the new items; the current discount ... is a great shopping season. Therefore, BamboofloorChina.com spares no ... new customers. All practical items offered by BamboofloorChina.com are ...
(Date:9/16/2014)... UK report a poorer experience of care during pregnancy ... their care, suggests a new study published today (17 ... and Gynaecology ( BJOG ). , Differences in ... in many areas and have provided the focus for ... inequalities. , The Oxford University study, funded by the ...
(Date:9/16/2014)... Holganix, an elite member of the Inc ... the country, produces an organic Bionutritional product that promotes ... decreasing disease and insect damage though significant root and ... hold its third annual Bionutritional Summit at the Seelbach ... 1:00 P.M. through 6:00 P.M., the day before the ...
Breaking Medicine News(10 mins):Health News:ICS Learning Group Wins Gold in the 2014 Brandon Hall Excellence Competition for Best Use of Games and Simulations for Learning 2Health News:Health.Verticalize Rebrands as Health Network After Growing to 15 Million Users in Less Than One Year 2Health News:Health.Verticalize Rebrands as Health Network After Growing to 15 Million Users in Less Than One Year 3Health News:BamboofloorChina.com Announces Its Promotion For Strand Woven Bamboo Floors 2Health News:A greater focus on socially disadvantaged women is needed to improve maternity care in England 2Health News:Holganix Holds 3rd Annual Bionutrional Summit in Louisville, Kentucky 2
... Medical School in the South West of England have ... out of hours services in primary care are reluctant ... and carried out telephone interviews with 27 patients who ... practice cover in the evenings and weekends in England. ...
... WANTAGH, N.Y., Nov. 29 As family members age, ... performing daily,tasks, such as cooking and laundry. Some need ... professional medical care, and most,want to stay in the ... how to keep their parents safe, healthy and cared ...
... U.S. is caused by a form of bacteria, the ... It typically begins with a bulls-eye skin rash, accompanied ... If diagnosed early, Lyme can be treated successfully within ... Nearly 60 percent of patients who do not receive ...
... Appointed Worldwide Managing Partners, NEW YORK, Nov. ... the,largest fully integrated, global health marketing and communications ... the credit going to,its unique leadership team whose ... leadership, effective immediately, Doug Burcin and Donna,Murphy, Partners, ...
... -- There are estimated to be ... diagnosed with chronic Immune Thrombocytopenic Purpura (ITP), an ... platelets in their blood -- causing bruises, nosebleeds ... of an international multicenter clinical research study led ...
... Receives Failing Grades on Key Benchmarks, WASHINGTON, ... its first-ever state-specific Report,Card on Lung Cancer. The ... lethal disease by the state of Massachusetts. LCA-MA ... Lung cancer is the number one cause of ...
Cached Medicine News:Health News:Out of hours doctors reluctant to do home visits, say patients 2Health News:Finding Ways for Seniors to Stay Safe, Healthy... and Home 2Health News:Finding Ways for Seniors to Stay Safe, Healthy... and Home 3Health News:Antibody responses in patients with Lyme arthritis 2Health News:Antibody responses in patients with Lyme arthritis 3Health News:World's Largest Fully Integrated, Global Health Marketing and Communications Group Appoints Global Leadership Team 2Health News:World's Largest Fully Integrated, Global Health Marketing and Communications Group Appoints Global Leadership Team 3Health News:Eltrombopag studied in Idiopathic Thrombocytopenic Purpura 2Health News:Lung Cancer Alliance-Massachusetts Issues Inaugural State-Specific Report Card on Lung Cancer 2
(Date:9/16/2014)... Tenn. , Sept. 16, 2014 A ... investigators has found the chemotherapy dose threshold below ... normal sperm production. The study appears in September 17 ... By clarifying which patients are at highest risk ... findings to eventually increase use of pre-treatment fertility preservation ...
(Date:9/16/2014)... -- Chindex International, Inc. ("Chindex" or the "Company") (Nasdaq: ... meeting of stockholders held today, the Company,s stockholders adopted ... and among the Company, Healthy Harmony Holdings, L.P. ("Parent"), ... an affiliate of TPG, Shanghai Fosun Pharmaceutical (Group) Co., ... CEO of the Company. The Merger Agreement ...
(Date:9/16/2014)... , Sept. 16, 2014 Research and Markets ... Vaccines Market 2014-2018" report to their offering. ... immunity of animals. Animal vaccines are generally prepared from weakened ... in their healthy state. Some of the animal vaccines are ... as protein subunits or toxic components. These ...
Breaking Medicine Technology:Improved risk identification will aid fertility preservation in young male cancer patients 2Improved risk identification will aid fertility preservation in young male cancer patients 3Improved risk identification will aid fertility preservation in young male cancer patients 4Chindex Stockholders Approve Merger 2Chindex Stockholders Approve Merger 3Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 2Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 3
... BioStorage Technologies, Inc., a worldwide provider of long- and ... logistics, will expand its European operations with the opening ... full-service biorepository in Frankfurt, Germany. , BioStorage Technologies, expanded ... plan to accommodate a rapidly growing list of customers ...
... Oct. 21 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHMD) ... bavituximab in combination with docetaxel in patients with advanced breast ... planned treatment cycles in the Phase II study showed that ... the trial achieved an objective tumor response according to RECIST ...
Cached Medicine Technology:BioStorage Technologies, Inc., Accelerates European Expansion with Opening of New German Facility 2Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer 2Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer 3Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer 4
... The Accutest H. pylori WB ... for the qualitative detection of ... pylori in human whole blood. ... as an aid in the ...
... Rapid 5 minutes immunoassay, based on ... a monoclonal antibody, for the qualitative ... human stool. The Premier Platinum HpSA, ... after extensive evaluation, was accepted as ...
Unitary one step immuno-chromatographic assay for the qualitative detection of infectious mononucleosis heterophile antibodies in human serum, plasma or whole blood....
The NOW® Flu B test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results an...
Medicine Products: